Search Results for 'production'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
-
Breaking News | Facilities | Industry News
Evergreen Expands Alpha Radiopharmaceutical Production Capabilities
A GMP state-of-the-art alpha emitter production center will be integrated into Evergreen’s existing facility.07.20.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
ImmVira Launches Pilot-scale Production Line
To expedite the advancement of next-generation oncolytic virus clinical trials.07.20.21
-
Aseptic Processing | Drug Delivery
New Horizons in Lipid Nano Particle Production
A revolution has taken place in the process for producing Lipid Nano Particles suitable for drug products such as vaccines. Learn more in this Aug 10 webinar.07.13.21
-
Aseptic Processing | Breaking News | Fill/Finish | Industry News | Parenterals
Swiss Government Turns to Swissfillon for COVID-19 Test Kit Production
Drug product CMO specialist adapts to provide 0.8 million prefilled syringes.07.08.21
-
VectorBuilder, Univercells Form Viral Vector Production Pact
Aims to develop a portfolio of optimized viral vector manufacturing protocols.07.06.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Rentschler Expands Complex Antibodies Production in Germany
Expands capacity with 2,000-liter bioreactor to address increasing demand for complex antibodies.06.30.21
-
eTheRNA, Quantoom Collaborate to Develop Novel RNA Production System
Aims to develop an RNA production system for both research and GMP-grade material.06.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate
Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.06.25.21
-
Breaking News | Industry News | Solid Dosage/Creams/Ointments
Mikart Expands Oral Solids Production Capabilities
Acquires Korsch XM12 to meet client demands for complex formulation development and production of oral solid dose products.06.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Yposkesi to Build Second Commercial Bioproduction Site
Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies
Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.06.10.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Avantor Boosts Global Production of Single Use Technologies
To increase single-use manufacturing footprint by 30% and double its cleanroom space in the U.S. and Europe.Kristin Brooks 05.14.21
-
Avantor Expands Global Production of Single-Use Technologies
To increase single-use manufacturing footprint by 30% and double cleanroom space.Videos
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Richter-Helm Triples cGMP Production Capacity
Will invest close to €70 million to triple current biologic production capacity and expand existing warehouse, lab, and administration buildings.Kristin Brooks 05.06.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Validation
ADMA Receives FDA Approval for Increased IVIG Production Scale
Increases plant manufacturing capacity from 400,000L to 600,000L.Tim Wright, Editor, Contract Pharma 04.29.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Lonza Doubles Drug Substance Production for Moderna’s COVID-19 Vaccine
New agreement for three additional production lines at Lonza’s site in Visp, Switzerland.Tim Wright, Editor, Contract Pharma 04.29.21
-
Breaking News | cGMP Manufacture | Industry News
FDA Approves ADMA Biologics Increased IVIG Production
Expanded manufacturing process enables fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin.Kristin Brooks 04.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Invests in Cutting Edge Vax Production Site in Singapore
The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.Kristin Brooks 04.12.21
-
Drug Delivery | Logistics
Vetter Packaging Solutions
Vetter can help you identify and develop the right packaging strategies for your compound, from clinical dev to commercialization to life cycle management.
-
Aseptic Processing | Fill/Finish | Parenterals | Process Development | Scale-up/Technology Transfer
Vetter Commercial Manufacturing
Vetter’s decades of experience as a contract manufacturer providing fill & finish for injectable drugs helps deliver results for both large and small companies.
-
Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Microbiology
Vetter Development Service
With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval.
-
Aseptic Processing | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Aenova Expands Sterile Production Capacity
Increases output capabilities to 100 million ampoules and vials at Gronau site.Tim Wright, Editor, Contract Pharma 03.26.21
-
Breaking News | cGMP Manufacture | Industry News
EMA Approves BioNTech's COVID Vax Production at Marburg Site
Largest mRNA vaccine manufacturing site in Europe has annual production capacity of up to one billion doses of its COVID-19 vaccine.Kristin Brooks 03.26.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Northwest Biotherapeutics Adds Production Capacity at UK Facility
Dendritic cell vaccine production capacity for personalized immune therapies increases from about 4 - 6 patients per month to about 40 - 45 patients per month.Kristin Brooks 03.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioVaxys, Wuxi Biologics Enter Bioproduction Agreement
To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.Tim Wright, Editor, Contract Pharma 03.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Celonic to Boost Cell & Gene Therapy Production
Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.Tim Wright, Editor, Contract Pharma 03.05.21
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Novo Nordisk Invests $80M in Tablet Production
Expanding site in Måløv, Denmark that currently makes oral products to treat diabetes.Tim Wright, Editor, Contract Pharma 03.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Intravacc Unveils New Pilot Vaccine Production Facility
State-of-the-art pilot plant for production of vaccine candidates in clinical phase I & II research.Tim Wright, Editor, Contract Pharma 02.19.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CureVac, Rentschler Ramp up COVID Vax Production
Rentschler responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany.Kristin Brooks 02.01.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Valneva Begins COVID Vax Production to Optimize Potential Deliveries
Inactivated, adjuvanted COVID-19 vaccine candidate is in Phase 1/2 clinical development with initial results in April 2021.Kristin Brooks 01.28.21
-
Biologics, Proteins, Vaccines
The Future of Biologics: Accelerating Production, Reducing Costs
Yeast-based gene expression offers pharma the yield and efficiencies it needs to make pandemic-stopping vaccines faster and more economical.Mark Emalfarb, Dyadic 01.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.Contract Pharma Staff 01.11.21
-
Bio News | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Fareva Expands Sterile Production Capabilities
Grows footprint with site acquisition in France and Austria.Contract Pharma Staff 11.06.20
-
Bio News | Breaking News | cGMP Manufacture | Industry News
eTheRNA Extends mRNA Production Services
Adds high throughput research grade mRNA to its GMP capabilities.Contract Pharma Staff 11.03.20
-
Formulation Development
**ADVERTORIAL** Advanced Formulation Development by Design in the Context of Holistic Drug Production
A strong trend in drug substance and drug product biomanufacturing, as is for formulation, is that of increasing therapeutic complexity.Latika Bhonsle-Deeng, Rentschler Biopharma SE, and Konstantin Petropoulos, LEUKOCARE AG 10.14.20
-
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
FDA Approves First Drug Using AJIPHASE Production Process
AJIPHASE platform is for the development and cGMP manufacture of high quality and purity commercial quantities of oligonucleotides and peptides.Contract Pharma Staff 10.07.20
-
Breaking News | cGMP Manufacture | Industry News
BioNTech to Acquire Novartis Mfg. Site for COVID-19 Vax Production
Will accelerate BioNTech’s efforts to scale-up commercial manufacturing capacity for its mRNA COVID-19 vaccine candidate BNT162.Contract Pharma Staff 09.17.20
-
APIs
Production Scale Up to Meet COVID-19 Demand
Rigorous process design and a robust supply chain are essential to support rapid scale up of API production in response to COVID-19.Ilan Avni, Wavelength Pharmaceuticals 09.09.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
JanOne Prepares for GMP Production
Bottling and labeling of clinical trial batches are expected to begin in early October led by Eurofins CDMO.Contract Pharma Staff 09.08.20
-
Breaking News | Excipients | Facilities | Industry News
JRS Pharma Receives EXCiPACT GMP Certification for the Production of MCC
The certificate for Changzhou, China facilities helps drug manufacturers reduce efforts and costs.Contract Pharma Staff 09.01.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic
COVID-19 clinical trial planned for Q1 2021 supported by Canadian Government.08.28.20
-
How One CDMO Used an Innovative Technology to Overcome Viral Vaccine Production Challenges
Join us for a webinar on 8/18 to learn how Ology Biosciences is leveraging innovative technologies and expertise to bring vaccine production to the next level.07.20.20
-
Breaking News | Facilities | Industry News
SCA Pharma to Expand Sterile Meds Production Facility
Construction at Windsor will allow company to add second clean room.Contract Pharma Staff 07.17.20
-
Breaking News | Industry News | Packaging & Tracking
Bormioli Pharma Invests in Type I Glass Vial Production
Increases efficiency, reduces carbon footprint, and improves quality control standards and product finishing.Contract Pharma Staff 06.30.20
-
cGMP Manufacture | Scale-up/Technology Transfer | Supply Chain
Reducing Development-to-Production Timescales for COVID-19 Vaccine
The challenges moving from regulatory approval to full production and how they can be addressed at each step in the manufacturing process.Online Exclusives Kristin Brooks, Contract Pharma 06.15.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Grifols Begins Production of Anti-SARS-CoV-2 Hyperimmune Immunoglobulin
Potential anti-COVID-19 passive immune therapy is part of a collaboration with the U.S. government, first doses for trials are expected July 2020Contract Pharma Staff 06.11.20
-
APIs | Breaking News | cGMP Manufacture | Excipients | Industry News
Evonik Commissions Advanced Biomaterials Production Facility
Expands range of CMO services for the scale-up and commercial manufacturing of customer’s own excipients in Birmingham, AL.Contract Pharma Staff 05.13.20
-
New, More Efficient, Technique for Liposome Production
There is growing interest in the field of nano-medicine and the biocompatibility performance of liposomes and lipid nanoparticles.
